Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
B-Lymphocytes | 11 | 2014 | 552 | 1.120 |
Why?
|
B-Lymphocyte Subsets | 4 | 2006 | 49 | 0.570 |
Why?
|
B-Cell Activating Factor | 2 | 2007 | 9 | 0.560 |
Why?
|
Homeostasis | 3 | 2006 | 343 | 0.430 |
Why?
|
B-Cell Activation Factor Receptor | 3 | 2009 | 5 | 0.370 |
Why?
|
Protein Kinases | 2 | 2007 | 139 | 0.330 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 62 | 0.310 |
Why?
|
Immunologic Memory | 4 | 2014 | 284 | 0.280 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2006 | 2 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 187 | 0.260 |
Why?
|
Signal Transduction | 6 | 2009 | 2894 | 0.260 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 316 | 0.250 |
Why?
|
Lymphocyte Activation | 4 | 2014 | 742 | 0.250 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2015 | 16 | 0.230 |
Why?
|
Respiratory Syncytial Virus Vaccines | 2 | 2015 | 20 | 0.230 |
Why?
|
Viral Fusion Proteins | 2 | 2015 | 74 | 0.230 |
Why?
|
Lymphopenia | 2 | 2003 | 35 | 0.220 |
Why?
|
Respiratory Syncytial Virus, Human | 2 | 2014 | 22 | 0.210 |
Why?
|
Interphase | 1 | 2002 | 68 | 0.200 |
Why?
|
Mice | 15 | 2014 | 10346 | 0.200 |
Why?
|
Germinal Center | 2 | 2014 | 37 | 0.190 |
Why?
|
NF-kappa B | 3 | 2008 | 462 | 0.170 |
Why?
|
Mice, Knockout | 8 | 2014 | 1999 | 0.170 |
Why?
|
Cytidine Deaminase | 2 | 2014 | 84 | 0.170 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2007 | 113 | 0.170 |
Why?
|
Mice, SCID | 5 | 2008 | 509 | 0.160 |
Why?
|
Animals | 17 | 2015 | 19771 | 0.160 |
Why?
|
Cell Survival | 4 | 2009 | 558 | 0.150 |
Why?
|
Newcastle disease virus | 3 | 2015 | 86 | 0.150 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2009 | 58 | 0.150 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2008 | 78 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-rel | 2 | 2009 | 15 | 0.130 |
Why?
|
Mice, Inbred A | 3 | 2006 | 20 | 0.130 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2015 | 17 | 0.120 |
Why?
|
Neoplasm Proteins | 2 | 2007 | 277 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 3 | 2015 | 502 | 0.110 |
Why?
|
Endonucleases | 1 | 2014 | 81 | 0.110 |
Why?
|
Flow Cytometry | 3 | 2014 | 639 | 0.110 |
Why?
|
Mice, Inbred NOD | 3 | 2008 | 516 | 0.100 |
Why?
|
DNA Damage | 1 | 2014 | 281 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2009 | 1297 | 0.100 |
Why?
|
Viral Vaccines | 1 | 2012 | 49 | 0.100 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2014 | 14 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2012 | 240 | 0.090 |
Why?
|
Immunoglobulin Class Switching | 2 | 2014 | 80 | 0.090 |
Why?
|
Adoptive Transfer | 3 | 2012 | 148 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2014 | 3221 | 0.090 |
Why?
|
Vaccines, Synthetic | 3 | 2015 | 68 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 98 | 0.080 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2009 | 3 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2008 | 697 | 0.080 |
Why?
|
Mice, Inbred CBA | 3 | 2003 | 83 | 0.080 |
Why?
|
Antigens, CD19 | 1 | 2008 | 20 | 0.080 |
Why?
|
Pneumococcal Vaccines | 1 | 2008 | 20 | 0.080 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2008 | 19 | 0.080 |
Why?
|
Cell Separation | 1 | 2008 | 147 | 0.080 |
Why?
|
Antibodies, Neutralizing | 3 | 2015 | 191 | 0.070 |
Why?
|
Apoptosis | 3 | 2014 | 1040 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 883 | 0.070 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2007 | 19 | 0.070 |
Why?
|
Immunoglobulin G | 3 | 2015 | 455 | 0.070 |
Why?
|
Spleen | 3 | 2005 | 486 | 0.070 |
Why?
|
Antibodies, Viral | 3 | 2015 | 305 | 0.070 |
Why?
|
Cell Size | 1 | 2007 | 41 | 0.070 |
Why?
|
Atrophy | 1 | 2007 | 68 | 0.070 |
Why?
|
Glycolysis | 1 | 2007 | 54 | 0.070 |
Why?
|
Sirolimus | 1 | 2007 | 77 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2007 | 115 | 0.070 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2006 | 2 | 0.070 |
Why?
|
Immunoglobulin M | 2 | 2004 | 113 | 0.070 |
Why?
|
B-Cell Maturation Antigen | 1 | 2006 | 18 | 0.070 |
Why?
|
Models, Immunological | 1 | 2006 | 80 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 59 | 0.070 |
Why?
|
Cell Death | 1 | 2007 | 272 | 0.070 |
Why?
|
Islets of Langerhans | 1 | 2007 | 267 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 304 | 0.060 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2005 | 13 | 0.060 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2005 | 12 | 0.060 |
Why?
|
DNA Glycosylases | 1 | 2005 | 16 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2006 | 120 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2008 | 604 | 0.060 |
Why?
|
Antigens, T-Independent | 1 | 2004 | 10 | 0.060 |
Why?
|
Borrelia Infections | 1 | 2004 | 11 | 0.060 |
Why?
|
Transfection | 1 | 2006 | 676 | 0.060 |
Why?
|
Neutralization Tests | 2 | 2015 | 125 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2007 | 1227 | 0.050 |
Why?
|
Relapsing Fever | 1 | 2003 | 16 | 0.050 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2002 | 22 | 0.050 |
Why?
|
Feedback | 1 | 2002 | 87 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2002 | 185 | 0.050 |
Why?
|
Interleukin-17 | 1 | 2002 | 82 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2014 | 2101 | 0.050 |
Why?
|
fas Receptor | 1 | 2002 | 54 | 0.050 |
Why?
|
Cell Division | 1 | 2002 | 443 | 0.050 |
Why?
|
Mice, Mutant Strains | 3 | 2007 | 304 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 449 | 0.040 |
Why?
|
Mutation | 1 | 2007 | 2471 | 0.040 |
Why?
|
Genetic Vectors | 2 | 2015 | 820 | 0.040 |
Why?
|
Transcription Factors | 1 | 2006 | 1459 | 0.040 |
Why?
|
Humans | 5 | 2008 | 60142 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 7 | 0.030 |
Why?
|
Multifunctional Enzymes | 1 | 2014 | 17 | 0.030 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2014 | 25 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2014 | 182 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 77 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 202 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 3619 | 0.030 |
Why?
|
Male | 4 | 2014 | 27975 | 0.030 |
Why?
|
Vaccines, Virosome | 1 | 2012 | 4 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2014 | 282 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 379 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 299 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2008 | 969 | 0.020 |
Why?
|
Female | 3 | 2015 | 31253 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 1539 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2014 | 943 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2008 | 53 | 0.020 |
Why?
|
Lymphopoiesis | 1 | 2008 | 25 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2009 | 325 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2008 | 94 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2008 | 125 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 1136 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 225 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 179 | 0.020 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2007 | 170 | 0.020 |
Why?
|
Immunity, Innate | 2 | 2003 | 768 | 0.020 |
Why?
|
Graft Rejection | 1 | 2007 | 264 | 0.020 |
Why?
|
Immunoglobulin Constant Regions | 1 | 2005 | 8 | 0.020 |
Why?
|
Uracil-DNA Glycosidase | 1 | 2005 | 9 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 584 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2005 | 237 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 1315 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 1157 | 0.010 |
Why?
|
Blood Bactericidal Activity | 1 | 2003 | 70 | 0.010 |
Why?
|
Borrelia | 1 | 2003 | 25 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 538 | 0.010 |
Why?
|
Agammaglobulinemia | 1 | 2002 | 8 | 0.010 |
Why?
|
Bacteremia | 1 | 2003 | 93 | 0.010 |
Why?
|
DNA | 1 | 2005 | 793 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 2087 | 0.010 |
Why?
|